All stories
Jump to date
Thursday, May 28 · 9 stories
- Industry
OIG Advisory Opinion Addresses Hospital Lease Arrangements; Construction Costs Stabilize
The HHS Office of Inspector General has issued a new advisory opinion on hospital lease arrangements, providing compliance guidance for healthcare real estate transactions. Separately, healthcare construction costs have leveled out after years of increases, potentially affecting facility expansion plans. These developments come as regional healthcare real estate markets show divergent growth patterns, with the Southeast and West Coast outperforming the Midwest and Northeast. For Medicaid managed care organizations with capital investments or provider network expansion plans, the OIG guidance clarifies Anti-Kickback Statute considerations in lease negotiations, while stabilizing construction costs may create opportunities for facility development.
- Industry
Big Five Medicaid Insurers Report Q1 2026 Financial and Enrollment Results
The five largest publicly-traded Medicaid managed care organizations—UnitedHealth Group, Elevance, CVS Health/Aetna, Centene, and Molina—have released first quarter 2026 financial and enrollment data. These companies collectively serve a majority of Medicaid managed care enrollees nationwide. Their quarterly results typically reveal trends in redetermination impacts, rate adequacy, medical loss ratios, and profitability that signal broader market conditions. State Medicaid directors and MCO executives monitor these earnings reports to benchmark performance, assess competitive positioning, and anticipate contract strategy shifts.
- Industry
NHeLP Executive Director Marks Medicaid Awareness Month, Cites Program's Reach to 70 Million
The National Health Law Program's new Executive Director released a reflection for Medicaid Awareness Month in April, highlighting the program's role in serving over 70 million enrollees. The statement emphasizes Medicaid's impact on health outcomes and economic security. This marks leadership commentary during a period of heightened attention to Medicaid coverage and access issues. The piece appears to be an advocacy blog post rather than a policy or regulatory announcement.
- Industry
Enhanced Premium Tax Credits Expire, Raising Marketplace Premiums for Low-Income Enrollees
Enhanced premium tax credits (ePTCs) for ACA Marketplace plans expired December 31, 2024, after Congress failed to extend the subsidy enhancement. Average monthly out-of-pocket premiums increased for millions of enrollees following the January 31 close of Open Enrollment. The expiration particularly affects low-income individuals who may have been previously eligible for both Marketplace subsidies and Medicaid, creating potential churn between coverage programs as affordability deteriorates.
- Industry
Trump Drug Pricing Deals Face First Test as New Launches Reveal List Prices
Seventeen pharmaceutical manufacturers that signed most-favored-nation pricing agreements with the Trump administration are beginning to launch new products, providing the first public test of whether these voluntary commitments will constrain launch prices. The agreements, which pledge U.S. list prices will not exceed prices in other developed nations, lack formal enforcement mechanisms and apply only to new products launched after signing. For Medicaid managed care organizations, these launches will reveal whether rebate strategies and supplemental rebate negotiations need adjustment, particularly if launch prices come in lower than historical benchmarks would predict.
- Industry
GSK hepatitis B drug achieves functional cure in 1 in 5 patients
An experimental GSK drug achieved functional cure in approximately 20% of chronic hepatitis B patients in new clinical trial data, significantly outperforming existing treatments. The results represent a potential breakthrough in treating chronic hepatitis B, which affects millions globally and can lead to liver cirrhosis and cancer. For Medicaid managed care organizations, improved hepatitis B treatments could reduce long-term pharmacy costs and downstream complications requiring expensive specialty care, particularly relevant given Medicaid's high enrollment of populations at elevated risk for chronic hepatitis B.
Wednesday, May 27 · 16 stories
- Industry
Sen. Durbin Claims Trump Administration Enables Tobacco Marketing to Minors
Senator Dick Durbin criticizes the Trump administration for allegedly allowing tobacco companies to market nicotine products to children. The opinion piece focuses on regulatory enforcement gaps rather than specific policy changes affecting Medicaid programs. While youth nicotine addiction can lead to long-term health consequences that may increase Medicaid costs, this op-ed does not address managed care operations, coverage policies, or state program administration. The piece represents political commentary on federal tobacco regulation rather than actionable guidance for Medicaid plans.
- Industry
KFF Analysis: Medicare Beneficiaries Face Affordability Challenges Across Coverage Types
A KFF brief examines health care affordability for Medicare beneficiaries, including younger adults with long-term disabilities. The analysis draws on multiple data sources to document out-of-pocket costs, premium burdens, and financial strain across traditional Medicare and Medicare Advantage populations. While not directly about Medicaid, the findings are relevant for dual-eligible special needs plans (D-SNPs) and state programs serving Medicare-Medicaid enrollees. Plans serving dual eligibles should consider how Medicare cost-sharing affects their members' total cost of care and care-seeking behavior.
- Industry
MACPAC Awards 10-Year Research Contracts to Five Firms for Medicaid Analysis
The Medicaid and CHIP Payment and Access Commission awarded indefinite delivery indefinite quantity contracts to five research firms—Abt Global, Acumen, American Institutes for Research, Altarum Institute, and one additional organization—covering fiscal years 2026 through 2035. These contractors will provide analytic support, data analysis, and policy research to inform MACPAC's congressional recommendations on Medicaid and CHIP. The awards position these firms as primary sources of evidence and analysis that will shape federal Medicaid policy recommendations over the next decade, including managed care delivery system design and payment policy.
- Industry
MACPAC Awards 10-Year Survey Data Contract to University of Minnesota SHADAC
The Medicaid and CHIP Payment and Access Commission awarded a decade-long indefinite delivery indefinite quantity contract for survey data analysis to the State Health Access Data Assistance Center at the University of Minnesota. The contract runs from fiscal years 2026 through 2035 and will support MACPAC's congressional reporting on Medicaid and CHIP access and enrollment trends. This contract supports the data infrastructure behind MACPAC's annual reports to Congress that influence federal managed care policy and payment methodologies.
- Industry
MACPAC Seeks Contractor for Survey Data Analysis Task Order Contract
The Medicaid and CHIP Payment and Access Commission (MACPAC) has issued a request for proposals for an indefinite delivery indefinite quantity (IDIQ) task order contract focused on survey data analysis and technical assistance. The RFP is available on www.sam.gov. MACPAC is an independent legislative branch agency that advises Congress on Medicaid and CHIP policy. This procurement supports MACPAC's ongoing work analyzing access, quality, and payment issues in Medicaid managed care and fee-for-service programs.
- Industry
MACPAC Seeks Contractors for Multi-Award IDIQ Contract Under NAICS 541720
The Medicaid and CHIP Payment and Access Commission has issued a solicitation for a multiple-award Indefinite Delivery Indefinite Quantity contract. The request for proposal is available on SAM.gov under NAICS code 541720 (Research and Development in the Social Sciences and Humanities). This procurement may signal MACPAC's research priorities for analyzing Medicaid managed care policy, payment methodologies, and access issues. Firms providing Medicaid research and technical assistance should review the solicitation details on SAM.gov for submission requirements and deadlines.
- Industry
CBPP Warns Trump Administration Budget Actions Threaten Medicaid, Safety Net Funding
The Center on Budget and Policy Priorities released multiple analyses warning that Trump Administration actions to block or redirect federal appropriations could disrupt Medicaid and other safety net programs. CBPP researchers called for Congressional appropriations guardrails in 2027 bills to prevent executive interference with enacted funding levels. The organization also flagged House legislation that would make it easier to withhold federal funds from states and programs. These budget control efforts could affect Medicaid managed care organizations through delayed capitation payments, withheld administrative funding, or disrupted federal match for state programs.
- Industry
CBPP Warns Budget Reconciliation Could Cut Safety Net Programs for Low-Income Families
The Center on Budget and Policy Priorities cautioned that House Republicans may use budget reconciliation to enact spending cuts affecting families struggling with basic needs, including housing assistance. CBPP noted that 76% of low-income renters eligible for federal rental assistance currently receive no aid. The organization called for Congress to increase affordable housing resources in upcoming 2027 appropriations legislation. While not Medicaid-specific, reconciliation processes have historically been used to restructure Medicaid financing and eligibility.
- Industry
Stanford Pilots Patient Input Process for Clinical AI Tool Adoption
Stanford Health Care has implemented a patient engagement process to gather feedback before deploying new artificial intelligence tools in clinical settings. The health system is soliciting patient perspectives on proposed AI applications to identify concerns and implementation challenges before rollout. This approach represents an emerging practice in health system governance as AI tools become more prevalent in clinical workflows. For Medicaid managed care organizations, patient engagement protocols for AI adoption may become relevant as plans evaluate clinical decision support tools, prior authorization algorithms, and utilization management systems.
- Industry
Nurse Convicted in Fatal Drug Error Advocates for Hospital Safety Improvements
RaDonda Vaught, a nurse convicted of negligent homicide for accidentally dispensing a deadly drug to a patient, now speaks publicly about hospital safety in the era of automation and AI. Her case highlights systemic issues in medication safety protocols that could affect patient care quality in Medicaid managed care networks. Healthcare organizations are increasingly focused on preventing similar incidents through improved safety systems and technology. This case serves as a reminder for MCOs to ensure their provider networks maintain robust medication safety protocols and error prevention systems.
- Industry
Trump Stock Purchase in Eli Lilly Raises Conflict Questions
Former President Trump purchased stock in Eli Lilly while his administration implemented policies that benefited the pharmaceutical company. The investment timing coincided with regulatory decisions favorable to drugmakers. This highlights ongoing concerns about potential conflicts of interest between policymakers and pharmaceutical companies. Medicaid managed care organizations should monitor how political relationships may influence drug pricing and coverage policies.
- Industry
Researchers Identify Medical Routines Older Adults May Not Need
New research identifies additional medical screenings and treatments that may provide limited benefit for older patients. The findings could influence clinical guidelines and coverage decisions for Medicare Advantage and dual-eligible special needs plans. Healthcare providers and managed care organizations serving older populations should review their care protocols and utilization management policies. The research adds to growing evidence supporting age-appropriate care that avoids unnecessary interventions for elderly beneficiaries.
- Industry
KFF CEO Drew Altman Announces Retirement, Larry Levitt and Mollyann Brodie Named Successors
Drew Altman, founding CEO of KFF (Kaiser Family Foundation), announced his retirement after nearly 40 years leading the health policy research organization. Larry Levitt and Mollyann Brodie will assume joint leadership roles in 2024, bringing six decades of combined experience at KFF. The transition affects one of the most influential health policy research organizations that regularly produces Medicaid analysis, polling, and policy briefs. The leadership change may influence the organization's future research priorities and policy positions on Medicaid managed care issues.
- Industry
HCA Healthcare Scales AI Across Clinical Operations with Clinician-Led Development
HCA Healthcare has implemented AI solutions across its health system operations through a systematic approach involving clinician engagement from development through deployment. The health system focuses on careful testing and customization of AI tools for clinical care and hospital operations, with nurses and physicians serving as primary end users throughout the process. This represents a scaled approach to healthcare AI implementation that other health systems and managed care organizations are watching for operational efficiency and care quality improvements. The initiative demonstrates how large healthcare organizations are integrating AI into everyday clinical workflows.